{"id":"https://openalex.org/W7202201217","doi":"https://doi.org/10.3389/fbinf.2026.1873262","title":"Design and in silico evaluation of Thiazole\u2013Isoxazole hybrids as PPAR\u03b3-Targeted antidiabetic agents","display_name":"Design and in silico evaluation of Thiazole\u2013Isoxazole hybrids as PPAR\u03b3-Targeted antidiabetic agents","alternate_titles":[],"publication_year":2026,"publication_date":"2026-08-11","ids":{"openalex":"https://openalex.org/W7202201217","doi":"https://doi.org/10.3389/fbinf.2026.1873262","pmid":"https://pubmed.ncbi.nlm.nih.gov/42643303","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13503372"},"language":"en","primary_location":{"id":"doi:10.3389/fbinf.2026.1873262","doi":"https://doi.org/10.3389/fbinf.2026.1873262","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fbinf.2026.1873262","pdf_url":"https://www.frontiersin.org/journals/bioinformatics/articles/10.3389/fbinf.2026.1873262/pdf","source":{"id":"https://openalex.org/S4210219554","display_name":"Frontiers in Bioinformatics","issn_l":"2673-7647","issn":["2673-7647"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Bioinformatics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7202201217"],"child_works_count":5,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/bioinformatics/articles/10.3389/fbinf.2026.1873262/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5121453480","display_name":"Abhirami PV","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1333540553","display_name":"Nitte University","ror":"https://ror.org/029nydt37","country_code":"IN","type":"education","lineage":["https://openalex.org/I1333540553"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Abhirami PV","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Nitte (Deemed to be University), Mangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Nitte (Deemed to be University), Mangalore, India","institution_ids":["https://openalex.org/I1333540553"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064881546","display_name":"Gupta Dheeraj Rajesh","orcid":"https://orcid.org/0000-0003-3194-0268","observed_orcids":["https://orcid.org/0000-0003-3194-0268"]},"institutions":[{"id":"https://openalex.org/I1333540553","display_name":"Nitte University","ror":"https://ror.org/029nydt37","country_code":"IN","type":"education","lineage":["https://openalex.org/I1333540553"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Gupta Dheeraj Rajesh","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Nitte (Deemed to be University), Mangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Nitte (Deemed to be University), Mangalore, India","institution_ids":["https://openalex.org/I1333540553"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089638836","display_name":"N. V. L. Sirisha Mulukuri","orcid":"https://orcid.org/0000-0001-6481-1601","observed_orcids":["https://orcid.org/0000-0001-6481-1601"]},"institutions":[{"id":"https://openalex.org/I1333540553","display_name":"Nitte University","ror":"https://ror.org/029nydt37","country_code":"IN","type":"education","lineage":["https://openalex.org/I1333540553"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"N. V. L. Sirisha Mulukuri","raw_affiliation_strings":["Department of Pharmacognosy, Nitte College of Pharmaceutical Sciences (NCOPS), Nitte (Deemed to be University), Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacognosy, Nitte College of Pharmaceutical Sciences (NCOPS), Nitte (Deemed to be University), Bangalore, India","institution_ids":["https://openalex.org/I1333540553"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106864538","display_name":"A. Ranjitha","orcid":"https://orcid.org/0009-0007-4974-6355","observed_orcids":["https://orcid.org/0009-0007-4974-6355"]},"institutions":[{"id":"https://openalex.org/I1333540553","display_name":"Nitte University","ror":"https://ror.org/029nydt37","country_code":"IN","type":"education","lineage":["https://openalex.org/I1333540553"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ranjitha A","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Nitte (Deemed to be University), Mangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Nitte (Deemed to be University), Mangalore, India","institution_ids":["https://openalex.org/I1333540553"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101258688","display_name":"Niyas Rehman","orcid":"https://orcid.org/0009-0005-8015-365X","observed_orcids":["https://orcid.org/0009-0005-8015-365X"]},"institutions":[{"id":"https://openalex.org/I158688498","display_name":"Yenepoya University","ror":"https://ror.org/029zfa075","country_code":"IN","type":"education","lineage":["https://openalex.org/I158688498"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Niyas Rehman","raw_affiliation_strings":["Centre for Integrative Omics Data Science, Yenepoya (Deemed to be University), Mangalore, Karnataka, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Integrative Omics Data Science, Yenepoya (Deemed to be University), Mangalore, Karnataka, India","institution_ids":["https://openalex.org/I158688498"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5146560840","display_name":"Shiv Basant Kumar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I78757542","display_name":"University of Newcastle Australia","ror":"https://ror.org/00eae9z71","country_code":"AU","type":"education","lineage":["https://openalex.org/I78757542"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Shiv Basant Kumar","raw_affiliation_strings":["Australian Plastic Research and Innovation Lab, Global Innovative Centre for Advanced Nanomaterials (GICAN), College of Engineering, Science and Environment (CESE), The University of Newcastle, Callaghan, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Australian Plastic Research and Innovation Lab, Global Innovative Centre for Advanced Nanomaterials (GICAN), College of Engineering, Science and Environment (CESE), The University of Newcastle, Callaghan, NSW, Australia","institution_ids":["https://openalex.org/I78757542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011668746","display_name":"Dileep Kumar","orcid":"https://orcid.org/0000-0002-3418-4325","observed_orcids":["https://orcid.org/0000-0002-3418-4325"]},"institutions":[{"id":"https://openalex.org/I164861460","display_name":"Manipal Academy of Higher Education","ror":"https://ror.org/02xzytt36","country_code":"IN","type":"education","lineage":["https://openalex.org/I164861460"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Dileep Kumar","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India","institution_ids":["https://openalex.org/I164861460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5146573995","display_name":"Pankaj Kumar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1333540553","display_name":"Nitte University","ror":"https://ror.org/029nydt37","country_code":"IN","type":"education","lineage":["https://openalex.org/I1333540553"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Pankaj Kumar","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Nitte (Deemed to be University), Mangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Nitte (Deemed to be University), Mangalore, India","institution_ids":["https://openalex.org/I1333540553"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5146573995"],"corresponding_institution_ids":["https://openalex.org/I1333540553"],"apc_list":{"value":2550,"currency":"CHF","value_usd":3077},"apc_paid":{"value":2550,"currency":"CHF","value_usd":3077},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":null,"first_page":"1873262","last_page":"1873262"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.5015000104904175,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.5015000104904175,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.2827000021934509,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.15109999477863312,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ppargamma","display_name":"PPAR\u03b3","score":0.9570000171661377},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.9300000071525574},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.972000002861023},{"id":"https://openalex.org/keywords/ligand-binding-domain","display_name":"ligand-binding domain","score":0.7749999761581421},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.7720000147819519},{"id":"https://openalex.org/keywords/molecular-dynamics-simulation","display_name":"molecular dynamics simulation","score":0.902999997138977},{"id":"https://openalex.org/keywords/drug-likeness","display_name":"drug-likeness","score":0.843999981880188},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.8690000176429749},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.5440000295639038}],"concepts":[{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.8429999947547913},{"id":"https://openalex.org/C2781269603","wikidata":"https://www.wikidata.org/wiki/Q899683","display_name":"Isoxazole","level":2,"score":0.8131999969482422},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5127999782562256},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4957999885082245},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.47690001130104065},{"id":"https://openalex.org/C6929976","wikidata":"https://www.wikidata.org/wiki/Q3771881","display_name":"Regulator","level":3,"score":0.4388999938964844},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.43650001287460327},{"id":"https://openalex.org/C3018667095","wikidata":"https://www.wikidata.org/wiki/Q3455903","display_name":"Glucose homeostasis","level":4,"score":0.43619999289512634},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4056999981403351},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.4041000008583069},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3549000024795532},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.32249999046325684},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3165000081062317},{"id":"https://openalex.org/C2780578515","wikidata":"https://www.wikidata.org/wiki/Q657193","display_name":"Metabolic syndrome","level":3,"score":0.29789999127388},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.2976999878883362},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2973000109195709},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.2964000105857849},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.27219998836517334},{"id":"https://openalex.org/C76923068","wikidata":"https://www.wikidata.org/wiki/Q3455903","display_name":"Blood sugar regulation","level":3,"score":0.2678999900817871},{"id":"https://openalex.org/C192989942","wikidata":"https://www.wikidata.org/wiki/Q68685","display_name":"Metabolic pathway","level":3,"score":0.25760000944137573},{"id":"https://openalex.org/C3018795828","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Binding affinities","level":3,"score":0.2533999979496002}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fbinf.2026.1873262","doi":"https://doi.org/10.3389/fbinf.2026.1873262","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fbinf.2026.1873262","pdf_url":"https://www.frontiersin.org/journals/bioinformatics/articles/10.3389/fbinf.2026.1873262/pdf","source":{"id":"https://openalex.org/S4210219554","display_name":"Frontiers in Bioinformatics","issn_l":"2673-7647","issn":["2673-7647"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Bioinformatics","raw_type":"journal-article"},{"id":"pmid:42643303","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42643303","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in bioinformatics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13503372","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13503372/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Bioinform","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:35f27a65b45745fba00fe4bdf1240e21","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/35f27a65b45745fba00fe4bdf1240e21","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Bioinformatics, Vol 6 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fbinf.2026.1873262","doi":"https://doi.org/10.3389/fbinf.2026.1873262","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fbinf.2026.1873262","pdf_url":"https://www.frontiersin.org/journals/bioinformatics/articles/10.3389/fbinf.2026.1873262/pdf","source":{"id":"https://openalex.org/S4210219554","display_name":"Frontiers in Bioinformatics","issn_l":"2673-7647","issn":["2673-7647"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Bioinformatics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7202201217.pdf","grobid_xml":"https://content.openalex.org/works/W7202201217.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1981021420","https://openalex.org/W2021628928","https://openalex.org/W2048233935","https://openalex.org/W2110641080","https://openalex.org/W2149302140","https://openalex.org/W2281101580","https://openalex.org/W2339122810","https://openalex.org/W2602598343","https://openalex.org/W2620932865","https://openalex.org/W2770315425","https://openalex.org/W2972869264","https://openalex.org/W2995147217","https://openalex.org/W2999090538","https://openalex.org/W3004397810","https://openalex.org/W3011543462","https://openalex.org/W3161603527","https://openalex.org/W3202287440","https://openalex.org/W3203952451","https://openalex.org/W4283270280","https://openalex.org/W4307812663","https://openalex.org/W4379052402","https://openalex.org/W4381429280","https://openalex.org/W4381661715","https://openalex.org/W4386998464","https://openalex.org/W4391550666","https://openalex.org/W4391967279","https://openalex.org/W4391975382","https://openalex.org/W4395010444","https://openalex.org/W4400581376","https://openalex.org/W4400983033","https://openalex.org/W4402542224","https://openalex.org/W4406194179"],"related_works":["https://openalex.org/W4410524604","https://openalex.org/W4386422463","https://openalex.org/W7213953686","https://openalex.org/W3126161372","https://openalex.org/W2997925093","https://openalex.org/W2781849219","https://openalex.org/W3022702766","https://openalex.org/W4285189195","https://openalex.org/W7089721633","https://openalex.org/W3109760492"],"abstract_inverted_index":{"Introduction":[0],"Diabetes":[1],"mellitus":[2],"is":[3,57],"a":[4,58,91,165],"chronic":[5],"metabolic":[6,23],"disorder":[7],"characterised":[8],"by":[9,46],"persistent":[10],"hyperglycemia":[11,21],"resulting":[12],"from":[13],"impaired":[14],"insulin":[15],"secretion,":[16],"action,":[17],"or":[18],"both.":[19],"Prolonged":[20],"disrupts":[22],"homeostasis":[24],"and":[25,36,49,63,66,72,78,84,89,139,164,200,208],"increases":[26],"the":[27,99,144,184],"risk":[28],"of":[29,61,94,103,129],"complications,":[30],"including":[31],"cardiovascular":[32],"disease,":[33],"neuropathy,":[34],"nephropathy,":[35],"retinopathy.":[37],"Current":[38],"therapies":[39],"target":[40],"multiple":[41],"pathways":[42],"but":[43],"are":[44],"limited":[45],"reduced":[47],"efficacy":[48,83],"adverse":[50],"effects.":[51],"Peroxisome":[52],"proliferator-activated":[53],"receptor":[54],"gamma":[55],"(PPAR\u03b3)":[56],"key":[59],"regulator":[60],"glucose":[62],"lipid":[64],"metabolism":[65],"an":[67],"important":[68],"therapeutic":[69],"target.":[70],"Thiazole":[71],"isoxazole":[73,96,186],"scaffolds":[74],"possess":[75],"antidiabetic":[76,107,191],"potential,":[77],"their":[79,176],"hybridisation":[80],"may":[81],"improve":[82],"safety.":[85],"Objective":[86],"To":[87],"design":[88],"evaluate":[90],"novel":[92],"series":[93],"thiazole-linked":[95,185],"derivatives":[97],"targeting":[98],"alternate":[100],"ligand-binding":[101],"domain":[102],"PPAR\u03b3":[104,117],"for":[105],"potential":[106],"activity.":[108],"Result":[109],"The":[110],"designed":[111],"compounds":[112],"(C1\u2013C210)":[113],"were":[114],"docked":[115],"into":[116],"(Protein":[118],"Data":[119],"Bank:":[120],"5":[121],"GTN),":[122],"yielding":[123],"nine":[124],"candidates":[125],"with":[126,141],"binding":[127],"affinities":[128],"\u221211.11":[130],"to":[131],"\u22129.97":[132],"kcal/mol.":[133],"Reference":[134],"ligands":[135],"included":[136],"pioglitazone,":[137],"Q-35,":[138],"S-35,":[140],"C139":[142,188],"showing":[143],"highest":[145],"affinity.":[146],"Molecular":[147],"dynamics":[148],"simulations":[149],"(200":[150],"ns)":[151],"confirmed":[152],"stability.":[153],"Advanced":[154],"Trajectory":[155],"analyses":[156],"indicate":[157],"favourable":[158],"conformational":[159,168],"sampling,":[160],"correlated":[161],"residue":[162],"motions,":[163],"relatively":[166],"confined":[167],"space.":[169],"In":[170,180],"silico":[171],"drug-likeness":[172],"profiling":[173],"further":[174,202],"supported":[175],"activity":[177,192],"profile.":[178],"Conclusion":[179],"this":[181],"computational":[182],"study,":[183],"compound":[187],"demonstrated":[189],"probable":[190],"against":[193],"PPAR\u03b3.":[194],"However,":[195],"these":[196],"findings":[197],"remain":[198],"predictive":[199],"require":[201],"validation":[203],"through":[204],"comprehensive":[205],"in":[206,209],"vitro":[207],"vivo":[210],"studies.":[211]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7202201217","counts_by_year":[],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2026-08-12T00:00:00"}
